A DOUBLE-BLIND, PLACEBO CONTROLLED, CROSS-OVER COMPARISON OF THE ANALGESIC EFFECT OF IBUPROFEN 400 MG AND 800 MG ON LASER-INDUCED PAIN

被引:32
作者
NIELSEN, JC
BJERRING, P
ARENDTNIELSEN, L
PETTERSON, KJ
机构
[1] AALBORG UNIV,DEPT MED INFORMAT,DK-9000 AALBORG,DENMARK
[2] MARSELISBORG HOSP,DEPT DERMATOL,DK-8000 AARHUS,DENMARK
[3] ASTRA RES CTR AB,SODERTALJE,SWEDEN
关键词
IBUPROFEN; ANALGESIA; EXPERIMENTAL PAIN; PLASMA CONCENTRATION; LASER STIMULATION;
D O I
10.1111/j.1365-2125.1990.tb03840.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The analgesic efficacy of single oral doses (400 mg, 800 mg) of ibuprofen on argon laser-induced pain was studied in a double-blind, placebo controlled, three way cross-over comparison. Ten healthy volunteers participated. 2. Pain thresholds and plasma concentrations of the S- and R-enantiomers of ibuprofen were measured every hour up to 8 h after medication. 3. Ibuprofen (400 mg) produced an analgesic effect significantly superior (P < 0.05) to placebo 1-4 h after medication. Ibuprofen (800 mg) was significantly superior to placebo 2-4 h after administration. No differences were found between 400 mg and 800 mg, when hourly threshold differences were compared. 4 Comparing total analgesic effect (area under effect curve), both active medications were superior to placebo (P < 0.01-0.05), and 400 mg was superior to 800 mg (P < 0.05). 5 Peak plasma concentrations of S- and R-ibuprofen occurred between 1.2 and 1.5 h. Concentrations after the 800 mg dose were higher than those after the 400 mg dose at all times.
引用
收藏
页码:711 / 715
页数:5
相关论文
共 37 条
[1]  
ADAMS SS, 1969, ARCH INT PHARMACOD T, V178, P115
[2]   PHARMACOKINETICS OF IBUPROFEN [J].
ALBERT, KS ;
GERNAAT, CM .
AMERICAN JOURNAL OF MEDICINE, 1984, 77 (1A) :40-46
[3]  
AMADIO P, 1984, AM J MED, P17
[4]   SENSORY AND PAIN THRESHOLD CHARACTERISTICS TO LASER STIMULI [J].
ARENDTNIELSEN, L ;
BJERRING, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (01) :35-42
[5]   IMPACT OF NON-NARCOTIC ORAL ANALGESICS ON PAIN MANAGEMENT [J].
BEAVER, WT .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (5A) :3-15
[6]  
BERGE OG, 1986, CEPHALALGIA, V4, P21
[7]  
BLOOMFIELD SS, 1974, CLIN PHARMACOL THER, V15, P565
[8]  
CHEN ACN, 1980, EXP BRAIN RES, V39, P359
[9]  
Cooper S A, 1986, Compend Contin Educ Dent, V7, P580
[10]  
COOPER SA, 1986, PHARMACOTHERAPY, V6, P267